Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica.
Eur J Pharm Sci
; 41(5): 623-30, 2010 Dec 23.
Article
in En
| MEDLINE
| ID: mdl-20850527
ABSTRACT
The aim of the present study was to evaluate the effect of release rate from ordered mesoporous silica materials on the rate and extent of absorption of the poorly soluble drug fenofibrate. Three ordered mesoporous silica materials with different pore diameter (7.3 nm, 4.4 nm and 2.7 nm) were synthesized and loaded with fenofibrate via impregnation. Release experiments were conducted under sink conditions and under supersaturating conditions in biorelevant media, simulating the fasted and the fed state. Subsequently, all silica-based formulations were evaluated in vivo (rat model). The release experiments under sink conditions indicated a clear increase in release rate with increasing pore size. However, under supersaturating conditions (FaSSIF), the, pharmaceutical performance (in terms of both the degree and duration of supersaturation), increased with decreasing pore size. The same trend was observed in vivo (fasted state) the area under the plasma concentration-time profile amounted to 102 ± 34 µMh, 86 ± 19 µMh and 20 ± 13 µMh for the materials with pore diameter of 2.7 nm, 4.4 nm and 7.3 nm, respectively. The results of this, study demonstrate that a decrease in drug release rate - and thus, a decrease of the rate at which supersaturation is created - is beneficial to the absorption of fenofibrate.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Fenofibrate
/
Pharmaceutical Preparations
/
Chemistry, Pharmaceutical
/
Silicon Dioxide
Limits:
Animals
Language:
En
Journal:
Eur J Pharm Sci
Journal subject:
FARMACIA
/
FARMACOLOGIA
/
QUIMICA
Year:
2010
Document type:
Article
Affiliation country:
Belgium